IP Library Granted Patent US 9,089,134
Granted Patent B2
US 9,089,134 · App. 13/958,547 · Granted Jul 28, 2015

Targeting delivery of anti-fungal agents

Inventors: Thomas Meehan (El Dorado Hills, CA); Quyen Ong (Irvine, CA)
Assignee: EDH Biotech Corp
A01N43/24A01N63/02A61K31/7048A61K47/24C07F9/106C07F9/65583
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,089,134
App. No.
13/958,547
Granted
Jul 28, 2015
Kind
B2
Abstract

The present application discloses a targeting composition that actively targets chitin-like materials, such as those found in fungi, a drug delivery vehicle comprising a micelle that comprises the targeting composition and one or more anti-fungal drugs, and methods of using the drug delivery vehicle.

Claims (7)

1. A chitin-targeting agent having the following structure:

2. A targeted drug delivery vehicle composed of a block copolymer micelle comprising 20% (molar basis) of the targeting agent of claim 1 and 80% (molar basis) of a phospholipid comprising DSPE-PEG 2000 -OCH 3 .

3. The targeted drug delivery vehicle of claim 2 , further comprising an antifungal drug selected from the group consisting of Amphotericin B, an echinocandin, azole, allosamidin, anidulafungin, bifonazole, butenafine, butoconazole, candicidin, caspofungin, cerulenin, chloroxine, ciclopirox, clioquinol, clotrimazole, econazole, fluconazole, flucytosine, griseofulvin, itraconazole, ketoconazole, micafungin, miconazole, naftifine, natamycin, nystatin, oxiconazole, posaconazole, sertaconazole, terbinafine, terconazole, tioconazole, and voriconazole.

4. The targeted drug delivery vehicle of claim 2 , wherein the micelle encapsulates an antifungal drug Amphotericin B.

5. A method of preparing a micelle according to claim 2 , comprising adding a targeting agent according to claim 1 to one or more phospholipids.

6. The method of claim 5 , wherein the phospholipid comprises phosphatidylethanolamine, optionally covalently linked to polyethylene glycol.

7. The method of claim 6 , wherein the phospholipid further comprises phosphatidylserine, phosphatidylinositol, phosphatidylinositol phosphate, phosphatidylglycerol, or phosphatidylglycerol phosphate, optionally covalently linked to polyethylene glycol.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 6, 2015
From: ONG, QUYEN; MEEHAN, THOMAS
To: EDH BIOTECH CORP
Reel/Frame 035798/0354 →
Continuity (1)
Related Publication 20150037396A1 · Feb 5, 2015